Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Capital Expenditures (2016 - 2026)

Kewaunee Scientific has reported Capital Expenditures over the past 17 years, most recently at $668000.0 for Q1 2026.

  • Quarterly results put Capital Expenditures at $668000.0 for Q1 2026, down 3.05% from a year ago — trailing twelve months through Jan 2026 was $3.5 million (up 34.08% YoY), and the annual figure for FY2025 was $2.2 million, down 50.47%.
  • Capital Expenditures for Q1 2026 was $668000.0 at Kewaunee Scientific, down from $1.6 million in the prior quarter.
  • Over the last five years, Capital Expenditures for KEQU hit a ceiling of $2.6 million in Q2 2023 and a floor of $278000.0 in Q3 2024.
  • Median Capital Expenditures over the past 5 years was $683000.0 (2024), compared with a mean of $863176.5.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 324.1% in 2023 and later tumbled 83.19% in 2024.
  • Kewaunee Scientific's Capital Expenditures stood at $529000.0 in 2022, then skyrocketed by 139.13% to $1.3 million in 2023, then tumbled by 46.01% to $683000.0 in 2024, then skyrocketed by 129.87% to $1.6 million in 2025, then tumbled by 57.45% to $668000.0 in 2026.
  • The last three reported values for Capital Expenditures were $668000.0 (Q1 2026), $1.6 million (Q4 2025), and $771000.0 (Q3 2025) per Business Quant data.